Download PDF

Other users also viewed these articles

P-107 CLINICAL SPECTRUM OF METABOLIC DYSFUNCTION¿ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PATIENTS WITH ALTERED ANKLE-BRACHIAL INDEX (ABI) AND CARDIOVASCULAR (CV) RISK FACTORS. Diana Karen Tapia Calderón; Francisco Alejandro Félix Téllez; Sergio Cerpa Cruz; José Roberto Barrientos Ávalos; José Antonio Velarde Chávez; Eliana Carolina Morel Cerda; Juan Manuel Aldana Ledesma; Edgar Santino García Jiménez; José Antonio Velarde Ruiz Velasco;
Ann Hepatol. 2024;29 Supl 3:
PREDICTIVE FACTORS OF RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN MEXICAN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS Fátima Higuera de la Tijera; Graciela Elia Castro Narro; Ana Cano Contreras; José Luis Pérez Hernández; Jorge Emilio Lira Vera; José Antonio Velarde Ruiz Velasco;
Ann Hepatol. 2025;30 Supl 2:
P-37 EXPERIENCE IN MEXICO WITH DIRECT ACTING ANTIVIRALS AS A TREATMENT FOR HEPATITIS C J.L. Pérez Hernández; Aldo Torre Delgadillo; Graciela Castro Narro; Eira Cerda Reyes; Mayra Virginia Ramos Gómez; Leonardo Juárez Chávezx; Margarita Dehesa Violante; Linda Muñoz Espinosa; Laura Cisneros Garza; Ignacio Aiza Haddad; José Antonio Velarde Ruiz Velasco; Raul Contreras Omaña; Nancy García Casarreal; Armando Carmona Castañea José; María de Fátima Higuera de la Tijera;
Ann Hepatol. 2021;24 Supl 1: